KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Assets: 2010-2025

Historic Assets for TherapeuticsMD (TXMD) over the last 11 years, with Sep 2025 value amounting to $38.7 million.

  • TherapeuticsMD's Assets fell 2.23% to $38.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $38.7 million, marking a year-over-year decrease of 2.23%. This contributed to the annual value of $38.8 million for FY2024, which is 10.36% down from last year.
  • TherapeuticsMD's Assets amounted to $38.7 million in Q3 2025, which was up 0.43% from $38.5 million recorded in Q2 2025.
  • TherapeuticsMD's 5-year Assets high stood at $239.3 million for Q1 2021, and its period low was $38.2 million during Q1 2025.
  • For the 3-year period, TherapeuticsMD's Assets averaged around $43.9 million, with its median value being $40.1 million (2024).
  • Its Assets has fluctuated over the past 5 years, first increased by 18.24% in 2021, then tumbled by 63.28% in 2023.
  • Quarterly analysis of 5 years shows TherapeuticsMD's Assets stood at $169.5 million in 2021, then slumped by 46.62% to $90.5 million in 2022, then crashed by 52.12% to $43.3 million in 2023, then decreased by 10.36% to $38.8 million in 2024, then decreased by 2.23% to $38.7 million in 2025.
  • Its last three reported values are $38.7 million in Q3 2025, $38.5 million for Q2 2025, and $38.2 million during Q1 2025.